USPTO 2015–2025 USPTO PatentsView US Corporation

Molecular Devices, Llc

USPTO PatentsView assignee record - 74 granted patents across 23 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.3

Avg claims per patent

+11%

5-year filing velocity

The verdict

Molecular holds 74 US patents across 23 technology areas, rank #4,728 of 50,000 tracked assignees.

#4,728
of 50,000 US assignees by volume: Top 17%
by Innovation Score (48.4/100): 18.3
avg claims per patent: +11%
filing velocity, last 5 yrs

Portfolio overview

Molecular Devices, Llc has been granted 74 US utility patents between 2015 and 2025, placing Molecular Devices, Llc at rank #4,728 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.3 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Molecular Devices, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Molecular sits between Kaohsiung Medical University (74 patents, rank #4,724) and Pierburg Gmbh (74 patents, rank #4,732) - the closest US assignees by grant volume. The composite Innovation Score of 48.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 39 grants, compared with 35 in the 2015–2019 window, a +11% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Molecular Devices, Llc's 18.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Molecular Devices, Llc against peers pursuing similar technology classes.

Kaohsiung Medical…

74
Keystone Retainin…

74
Luigi Lavazza S p…

74
Magnolia Medical

74
Nanning Fulian Fu…

74
Ncstar

74
Physik Instrument…

74
Pierburg

74
Molecular Devices ◀

74

What this shows Molecular holds 74 patents at rank #4,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Molecular

By rank, the assignees closest to #4,728 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Molecular's primary technology class.

Molecular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Molecular Devices, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	13.5%
2016	3	4.1%
2017	6	8.1%
2018	11	14.9%
2019	5	6.8%
2020	8	10.8%
2021	10	13.5%
2022	5	6.8%
2023	7	9.5%
2024	7	9.5%
2025	2	2.7%

Which technologies does Molecular Devices, Llc patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 40

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 26

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 25

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 20

G06F - ELECTRIC DIGITAL DATA PROCESSING 9

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 8

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 7

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 6

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 5

G01J - MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY 5

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 4

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

G01C - MEASURING DISTANCES, LEVELS OR BEARINGS; SURVEYING; NAVIGATION; GYROSCOPIC INSTRUMENTS; PHOTOGRAMMETRY OR VIDEOGRAMMETRY 2

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 2

Top 15 of 23 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#4,728

Across all tracked assignees

Innovation Score

48.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Molecular Devices, Llc hold?

Molecular Devices, Llc holds 74 US granted patents filed between 2015 and 2025, spanning 23 technology areas.

What is Molecular Devices, Llc's Innovation Score?

Molecular Devices, Llc has an Innovation Score of 48.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Molecular Devices, Llc focus on?

Molecular Devices, Llc's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 40 patents. The company has filed patents in 23 CPC subclasses total.

Is Molecular Devices, Llc's patent filing rate increasing or decreasing?

Molecular Devices, Llc's recent filing velocity is +11% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Molecular Devices, Llc's patents?

Molecular Devices, Llc's patents average 18.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Molecular Devices, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Molecular's 74 grants land it in the top 17% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Molecular ranks #4,728 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.